Cover Image

Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan

Shinichiro Ryuge1, Shi-Xu Jiang2, Mayuko Wada1, Ken Katono1, Maiko Iwasaki1, Akira Takakura1, Sakiko Otani1, Yuka Kimura1, Tomoya Fukui1, Masanori Yokoba1, Masaru Kubota1, Masato Katagiri1, Kazusige Hayakawa3, Noriyuki Masuda11Department of Respiratory Medicine, 2Department of Pathology, 3Department...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shinichiro Ryuge (Author), Shi-Xu Jiang (Author), Mayuko Wada (Author), Ken Katono (Author), et al (Author)
Format:	Book
Published:	Dove Medical Press, 2009-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
by: Ding Q, et al.
Published: (2013)

Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin
by: Michiko Yamamoto, et al.
Published: (2008)

IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2008)

Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study
by: Mengli Zheng, et al.
Published: (2016)

Risk factors associated with survival in surgically treated large cell neuroendocrine carcinoma of the lung
by: Hakan Keskin, et al.
Published: (2023)

CAPECITABINE AND IRINOTECAN AS FIRST- LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2010)

Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L
by: Adrien Labriet, et al.
Published: (2017)

A rare case of metastatic small cell neuroendocrine carcinoma of the lung presenting as isolated thrombocytopenia
by: Adreana DeMarinis, et al.
Published: (2019)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
by: Huiying Shi, et al.
Published: (2020)

Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma
by: Zuoyu Liang, et al.
Published: (2022)

Laparoscopically diagnosed and treated ruptured metastatic ovarian tumor
by: Mai Nishimura, et al.
Published: (2020)

Pulmonary Large Cell Neuroendocrine Carcinoma
by: Lan Yang, et al.
Published: (2022)

BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
by: Deyan Davidov
Published: (2014)

Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters
by: Esther Oyaga-Iriarte, et al.
Published: (2019)

Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure-safety analyses in patients with metastatic pancreatic cancer
by: Karl Brendel, et al.
Published: (2021)

Adverse event costs of systemic therapies for metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatinand irinotecan-based chemotherapy and biologics in the US
by: Victoria Federico Paly, et al.
Published: (2024)

A rare case of neuroendocrine carcinoma of the endometrium metastatic to the thyroid
by: Nancy Zhou, et al.
Published: (2021)

Signet ring: A rare morphology of metastatic neuroendocrine tumor
by: Manoj G Madakshira, et al.
Published: (2019)

ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients
by: Pau Riera, et al.
Published: (2020)

Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation
by: Wenqian Yang, et al.
Published: (2019)

Unknown primary large-cell neuroendocrine tumor
by: Sara Póvoa, et al.
Published: (2018)

Pulmonary Combined Large Cell Neuroendocrine Carcinoma
by: Meihui Li, et al.
Published: (2022)

Metastatic pulmonary tumor from type 3 gastric neuroendocrine tumor
by: Shuta Ohara, et al.
Published: (2021)

Chilean experience using "Theranostics" for treating metastatic neuroendocrine tumors with [177Lu]Lu DOTA-TATE
by: Horacio Amaral, et al.
Published: (2020)

A pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) (NET and undifferentiated carcinoma of the pancreas with osteoclast-like giant cells) with metastatic neuroendocrine component to the liver
by: Guofeng Gao, et al.
Published: (2021)

Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
by: Papadimitriou John C, et al.
Published: (2007)

Primary pure large cell neuroendocrine carcinoma of the ovary
by: Chen-Hsien Lin, et al.
Published: (2014)

Combined Adenosquamous and Large Cell Neuroendocrine Carcinoma of the Gallbladder
by: Jiyoon Jung, et al.
Published: (2018)

Post-Marketing Safety Study of Ramucirumab Plus FOLFIRI: Analysis of Age and Initial Dose of Irinotecan in Patients with Metastatic Colorectal Cancer
by: Toshiki Masuishi, et al.
Published: (2023)

Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report
by: Mingming Li, et al.
Published: (2019)

Advances in combined neuroendocrine carcinoma of lung cancer
by: Zesen Han, et al.
Published: (2024)

Incorporation of immunotherapy into the treatment of metastatic neuroendocrine carcinoma of the cervix: A case report
by: Akanksha Suresh, et al.
Published: (2023)

Advanced metastatic pancreatic neuroendocrine tumor treated successfully with peptide receptor radionuclide therapy: a case report
by: Amit Kumar, et al.
Published: (2022)

Herbal Medicines for Irinotecan-Induced Diarrhea
by: Liu Tang, et al.
Published: (2019)

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
by: Suenaga M, et al.
Published: (2015)

Large Cell Neuroendocrine Carcinoma of the Uterine Cervix Associated with Adenocarcinoma
by: Ma-Lee Ko, et al.
Published: (2007)

Primary endometrial large cell neuroendocrine carcinoma with melanocytic differentiation
by: Lucinda Calheiros Guimarães, et al.
Published: (2018)

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
by: Ortendahl JD, et al.
Published: (2017)

Metastatic well-differentiated neuroendocrine tumor in the breast: A case report and literature review
by: Dongfang Yu, et al.
Published: (2019)

Two cases of lung neuroendocrine carcinoma with carcinoid morphology
by: Kenji Inafuku, et al.
Published: (2019)